| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | mRNA binding | TARDBP DDX3Y ALYREF HNRNPA1L2 DDX50 HNRNPA1 HNRNPA1L3 HNRNPA2B1 HNRNPAB HNRNPA3 | 2.01e-07 | 694 | 35 | 10 | GO:0003729 |
| GeneOntologyMolecularFunction | G-rich strand telomeric DNA binding | 8.06e-07 | 11 | 35 | 3 | GO:0098505 | |
| GeneOntologyMolecularFunction | single-stranded telomeric DNA binding | 1.39e-06 | 13 | 35 | 3 | GO:0043047 | |
| GeneOntologyMolecularFunction | sequence-specific single stranded DNA binding | 2.21e-06 | 15 | 35 | 3 | GO:0098847 | |
| GeneOntologyMolecularFunction | regulatory RNA binding | 4.10e-06 | 62 | 35 | 4 | GO:0061980 | |
| GeneOntologyMolecularFunction | pre-mRNA binding | 4.66e-06 | 64 | 35 | 4 | GO:0036002 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR binding | 7.65e-06 | 276 | 35 | 6 | GO:0003730 | |
| GeneOntologyMolecularFunction | telomeric repeat-containing RNA binding | 8.94e-06 | 3 | 35 | 2 | GO:0061752 | |
| GeneOntologyMolecularFunction | RNA strand annealing activity | 2.97e-05 | 5 | 35 | 2 | GO:0033592 | |
| GeneOntologyMolecularFunction | telomeric DNA binding | 4.66e-05 | 40 | 35 | 3 | GO:0042162 | |
| GeneOntologyMolecularFunction | molecular condensate scaffold activity | 5.40e-05 | 42 | 35 | 3 | GO:0140693 | |
| GeneOntologyMolecularFunction | miRNA binding | 8.08e-05 | 48 | 35 | 3 | GO:0035198 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 8.64e-05 | 134 | 35 | 4 | GO:0003697 | |
| GeneOntologyMolecularFunction | DNA/DNA annealing activity | 1.63e-04 | 11 | 35 | 2 | GO:1990814 | |
| GeneOntologyMolecularFunction | annealing activity | 2.68e-04 | 14 | 35 | 2 | GO:0140666 | |
| GeneOntologyMolecularFunction | pre-mRNA intronic binding | 2.68e-04 | 14 | 35 | 2 | GO:0097157 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 3.43e-04 | 78 | 35 | 3 | GO:0003724 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 3.70e-04 | 80 | 35 | 3 | GO:0008186 | |
| GeneOntologyMolecularFunction | sequence-specific mRNA binding | 5.01e-04 | 19 | 35 | 2 | GO:1990825 | |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 8.04e-04 | 24 | 35 | 2 | GO:0140517 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 2.00e-03 | 1356 | 35 | 8 | GO:0060090 | |
| GeneOntologyMolecularFunction | helicase activity | 2.64e-03 | 158 | 35 | 3 | GO:0004386 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 3.52e-03 | 1160 | 35 | 7 | GO:0030674 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 5.88e-03 | 417 | 35 | 4 | GO:0140098 | |
| GeneOntologyBiologicalProcess | mRNA processing | TARDBP ALYREF HNRNPA1L2 SAFB HNRNPUL1 VIRMA HNRNPA1 HNRNPA1L3 HNRNPA2B1 DDX42 HNRNPA3 | 7.34e-10 | 551 | 34 | 11 | GO:0006397 |
| GeneOntologyBiologicalProcess | mRNA metabolic process | SP1 TARDBP ALYREF HNRNPA1L2 SAFB HNRNPUL1 VIRMA HNRNPA1 HNRNPA1L3 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 9.48e-10 | 917 | 34 | 13 | GO:0016071 |
| GeneOntologyBiologicalProcess | RNA splicing | TARDBP ALYREF HNRNPA1L2 HNRNPUL1 VIRMA HNRNPA1 HNRNPA1L3 HNRNPA2B1 DDX42 HNRNPA3 | 5.18e-09 | 502 | 34 | 10 | GO:0008380 |
| GeneOntologyBiologicalProcess | RNA localization | 5.47e-08 | 217 | 34 | 7 | GO:0006403 | |
| GeneOntologyBiologicalProcess | mRNA transport | 1.24e-07 | 145 | 34 | 6 | GO:0051028 | |
| GeneOntologyBiologicalProcess | RNA processing | TARDBP ALYREF HNRNPA1L2 SAFB HNRNPUL1 GAR1 VIRMA HNRNPA1 HNRNPA1L3 HNRNPA2B1 PIWIL3 DDX42 HNRNPA3 | 3.30e-07 | 1500 | 34 | 13 | GO:0006396 |
| GeneOntologyBiologicalProcess | RNA transport | 3.78e-07 | 175 | 34 | 6 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 3.78e-07 | 175 | 34 | 6 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 4.18e-07 | 178 | 34 | 6 | GO:0051236 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | HNRNPA1L2 HNRNPUL1 HNRNPA1 HNRNPA1L3 HNRNPA2B1 DDX42 HNRNPA3 | 1.61e-06 | 358 | 34 | 7 | GO:0000398 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | HNRNPA1L2 HNRNPUL1 HNRNPA1 HNRNPA1L3 HNRNPA2B1 DDX42 HNRNPA3 | 1.61e-06 | 358 | 34 | 7 | GO:0000377 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | HNRNPA1L2 HNRNPUL1 HNRNPA1 HNRNPA1L3 HNRNPA2B1 DDX42 HNRNPA3 | 1.73e-06 | 362 | 34 | 7 | GO:0000375 |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 2.95e-06 | 249 | 34 | 6 | GO:0015931 | |
| GeneOntologyBiologicalProcess | RNA export from nucleus | 1.84e-05 | 96 | 34 | 4 | GO:0006405 | |
| GeneOntologyBiologicalProcess | nuclear export | 2.35e-04 | 185 | 34 | 4 | GO:0051168 | |
| GeneOntologyBiologicalProcess | cellular response to potassium ion | 2.37e-04 | 14 | 34 | 2 | GO:0035865 | |
| GeneOntologyBiologicalProcess | mRNA export from nucleus | 2.45e-04 | 74 | 34 | 3 | GO:0006406 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 2.97e-04 | 79 | 34 | 3 | GO:0000380 | |
| GeneOntologyBiologicalProcess | nuclear transport | 3.62e-04 | 378 | 34 | 5 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 3.62e-04 | 378 | 34 | 5 | GO:0006913 | |
| GeneOntologyBiologicalProcess | positive regulation of action potential | 3.97e-04 | 18 | 34 | 2 | GO:0045760 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomere lengthening | 4.36e-04 | 90 | 34 | 3 | GO:0010833 | |
| GeneOntologyBiologicalProcess | response to potassium ion | 5.43e-04 | 21 | 34 | 2 | GO:0035864 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 7.44e-04 | 443 | 34 | 5 | GO:1903311 | |
| GeneOntologyBiologicalProcess | mRNA modification | 8.36e-04 | 26 | 34 | 2 | GO:0016556 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 8.91e-04 | 115 | 34 | 3 | GO:1903312 | |
| GeneOntologyBiologicalProcess | response to arsenic-containing substance | 1.69e-03 | 37 | 34 | 2 | GO:0046685 | |
| GeneOntologyBiologicalProcess | positive regulation of telomere maintenance via telomere lengthening | 1.88e-03 | 39 | 34 | 2 | GO:1904358 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 2.22e-03 | 158 | 34 | 3 | GO:0050684 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 1.24e-08 | 97 | 35 | 6 | GO:0071013 | |
| GeneOntologyCellularComponent | spliceosomal complex | 5.81e-08 | 215 | 35 | 7 | GO:0005681 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 4.14e-07 | 287 | 35 | 7 | GO:0035770 | |
| GeneOntologyCellularComponent | ribonucleoprotein complex | ALYREF HNRNPA1L2 HNRNPUL1 GAR1 LIMD1 HNRNPA1 HNRNPA1L3 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 2.36e-06 | 1194 | 35 | 11 | GO:1990904 |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 5.10e-06 | 269 | 35 | 6 | GO:0036464 | |
| GeneOntologyCellularComponent | nucleoplasmic periphery of the nuclear pore complex | 4.07e-05 | 6 | 35 | 2 | GO:1990826 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | ALYREF NUP214 HNRNPA1L2 GAR1 HNRNPA1 HNRNPA1L3 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 5.97e-05 | 1377 | 35 | 10 | GO:0140513 |
| GeneOntologyCellularComponent | neuronal ribonucleoprotein granule | 1.22e-04 | 10 | 35 | 2 | GO:0071598 | |
| GeneOntologyCellularComponent | Cajal body | 3.73e-04 | 84 | 35 | 3 | GO:0015030 | |
| GeneOntologyCellularComponent | nuclear body | 6.38e-04 | 903 | 35 | 7 | GO:0016604 | |
| GeneOntologyCellularComponent | nuclear speck | 7.10e-04 | 431 | 35 | 5 | GO:0016607 | |
| GeneOntologyCellularComponent | pole plasm | 1.07e-03 | 29 | 35 | 2 | GO:0045495 | |
| GeneOntologyCellularComponent | germ plasm | 1.07e-03 | 29 | 35 | 2 | GO:0060293 | |
| GeneOntologyCellularComponent | P granule | 1.07e-03 | 29 | 35 | 2 | GO:0043186 | |
| GeneOntologyCellularComponent | chromosome, telomeric region | 3.15e-03 | 176 | 35 | 3 | GO:0000781 | |
| HumanPheno | Ubiquitin-positive cerebral inclusion bodies | 1.04e-05 | 3 | 10 | 2 | HP:0012083 | |
| HumanPheno | Dyscalculia | 1.08e-05 | 24 | 10 | 3 | HP:0002442 | |
| HumanPheno | Amyotrophic lateral sclerosis | 9.58e-05 | 49 | 10 | 3 | HP:0007354 | |
| HumanPheno | Frontotemporal dementia | 1.14e-04 | 52 | 10 | 3 | HP:0002145 | |
| HumanPheno | Mutism | 1.43e-04 | 56 | 10 | 3 | HP:0002300 | |
| HumanPheno | Calvarial hyperostosis | 1.55e-04 | 10 | 10 | 2 | HP:0004490 | |
| HumanPheno | Hip pain | 2.27e-04 | 12 | 10 | 2 | HP:0030838 | |
| HumanPheno | Motor neuron atrophy | 2.34e-04 | 66 | 10 | 3 | HP:0007373 | |
| HumanPheno | Generalized amyotrophy | 5.12e-04 | 86 | 10 | 3 | HP:0003700 | |
| MousePheno | tongue muscle hypoplasia | 3.87e-06 | 2 | 28 | 2 | MP:0030421 | |
| MousePheno | abnormal branching involved in seminal vesicle morphogenesis | 2.32e-05 | 4 | 28 | 2 | MP:0013318 | |
| MousePheno | skeletal muscle hypoplasia | 3.85e-05 | 5 | 28 | 2 | MP:0009460 | |
| MousePheno | abnormal seminal vesicle development | 1.38e-04 | 9 | 28 | 2 | MP:0013317 | |
| MousePheno | perinatal lethality, complete penetrance | 3.99e-04 | 712 | 28 | 7 | MP:0011089 | |
| MousePheno | abnormal intercostal muscle morphology | 4.00e-04 | 15 | 28 | 2 | MP:0002280 | |
| MousePheno | muscle hypoplasia | 4.00e-04 | 15 | 28 | 2 | MP:0000734 | |
| MousePheno | abnormal tongue muscle morphology | 4.56e-04 | 16 | 28 | 2 | MP:0004136 | |
| MousePheno | decreased skeletal muscle size | 5.53e-04 | 81 | 28 | 3 | MP:0010240 | |
| MousePheno | neonatal lethality, complete penetrance | 5.55e-04 | 534 | 28 | 6 | MP:0011087 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | TARDBP HNRNPA1L2 SAFB SALL3 VIRMA HNRNPA1 KCNT1 SPINK5 HNRNPA3 | 5.72e-04 | 1269 | 28 | 9 | MP:0011111 |
| Domain | Nucleotide-bd_a/b_plait | TARDBP ALYREF HNRNPA1L2 SAFB DDX50 HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 4.60e-10 | 258 | 33 | 9 | IPR012677 |
| Domain | RRM_1 | TARDBP ALYREF HNRNPA1L2 SAFB HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 2.26e-09 | 208 | 33 | 8 | PF00076 |
| Domain | RRM | TARDBP ALYREF HNRNPA1L2 SAFB HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 3.16e-09 | 217 | 33 | 8 | SM00360 |
| Domain | RRM_dom | TARDBP ALYREF HNRNPA1L2 SAFB HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 4.50e-09 | 227 | 33 | 8 | IPR000504 |
| Domain | RRM | TARDBP ALYREF HNRNPA1L2 SAFB HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 4.99e-09 | 230 | 33 | 8 | PS50102 |
| Domain | HnRNPA1 | 5.03e-09 | 3 | 33 | 3 | PF11627 | |
| Domain | HnRNPA1 | 5.03e-09 | 3 | 33 | 3 | IPR021662 | |
| Domain | - | TARDBP ALYREF HNRNPA1L2 SAFB HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 7.92e-09 | 244 | 33 | 8 | 3.30.70.330 |
| Domain | RNA_helicase_DEAD_Q_motif | 3.75e-05 | 37 | 33 | 3 | IPR014014 | |
| Domain | Q_MOTIF | 3.75e-05 | 37 | 33 | 3 | PS51195 | |
| Domain | DEAD | 2.87e-04 | 73 | 33 | 3 | PF00270 | |
| Domain | DEAD/DEAH_box_helicase_dom | 2.87e-04 | 73 | 33 | 3 | IPR011545 | |
| Domain | - | 6.23e-04 | 21 | 33 | 2 | 1.10.720.30 | |
| Domain | SAP | 6.84e-04 | 22 | 33 | 2 | PF02037 | |
| Domain | SAP | 7.48e-04 | 23 | 33 | 2 | SM00513 | |
| Domain | Helicase_C | 8.80e-04 | 107 | 33 | 3 | PF00271 | |
| Domain | HELICc | 8.80e-04 | 107 | 33 | 3 | SM00490 | |
| Domain | SAP | 8.85e-04 | 25 | 33 | 2 | PS50800 | |
| Domain | SAP_dom | 8.85e-04 | 25 | 33 | 2 | IPR003034 | |
| Domain | Helicase_C | 9.04e-04 | 108 | 33 | 3 | IPR001650 | |
| Domain | HELICASE_CTER | 9.29e-04 | 109 | 33 | 3 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 9.29e-04 | 109 | 33 | 3 | PS51192 | |
| Domain | DEXDc | 9.29e-04 | 109 | 33 | 3 | SM00487 | |
| Domain | Helicase_ATP-bd | 9.54e-04 | 110 | 33 | 3 | IPR014001 | |
| Domain | DEAD_ATP_HELICASE | 1.36e-03 | 31 | 33 | 2 | PS00039 | |
| Domain | RNA-helicase_DEAD-box_CS | 1.54e-03 | 33 | 33 | 2 | IPR000629 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.13e-06 | 277 | 29 | 7 | MM15414 | |
| Pathway | WP_MRNA_PROCESSING | TARDBP ALYREF HNRNPA1L2 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 2.45e-06 | 451 | 29 | 8 | MM15946 |
| Pathway | REACTOME_MRNA_SPLICING | 2.82e-06 | 201 | 29 | 6 | MM15411 | |
| Pathway | KEGG_SPLICEOSOME | 5.48e-06 | 127 | 29 | 5 | M2044 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 2.00e-05 | 283 | 29 | 6 | M13087 | |
| Pathway | REACTOME_MRNA_SPLICING | 6.49e-05 | 212 | 29 | 5 | M14033 | |
| Pathway | WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM | 7.96e-05 | 113 | 29 | 4 | M48336 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 1.90e-04 | 612 | 29 | 7 | MM15547 | |
| Pathway | WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME | 4.42e-04 | 73 | 29 | 3 | M39401 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 5.29e-04 | 724 | 29 | 7 | M16843 | |
| Pathway | REACTOME_FGFR2_ALTERNATIVE_SPLICING | 6.13e-04 | 18 | 29 | 2 | MM15334 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | TARDBP DDX3Y ALYREF CAAP1 NUP214 HNRNPA1L2 SAFB SALL3 HNRNPUL1 DDX50 GAR1 TRIP12 HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 6.99e-18 | 954 | 35 | 17 | 36373674 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | TARDBP DDX3Y CAAP1 SAFB GPC2 HNRNPUL1 HRNR DDX50 GAR1 TRIP12 HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 4.08e-14 | 1082 | 35 | 15 | 38697112 |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | SP1 TARDBP ALYREF CAAP1 HNRNPA1L2 SAFB HNRNPUL1 ARID3A TRIP12 HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 | 7.97e-14 | 701 | 35 | 13 | 30196744 |
| Pubmed | TARDBP DDX3Y ALYREF SAFB HNRNPUL1 HRNR TRIP12 HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 | 1.00e-13 | 390 | 35 | 11 | 17643375 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TARDBP ALYREF NUP214 SAFB HNRNPUL1 HRNR DDX50 GAR1 TRIP12 HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 4.40e-13 | 1024 | 35 | 14 | 24711643 |
| Pubmed | TARDBP HNRNPA1L2 SAFB GAR1 HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 6.38e-12 | 172 | 35 | 8 | 26336360 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SP1 TARDBP ALYREF NUP214 SAFB HNRNPUL1 DDX50 GAR1 TRIP12 HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 1.01e-11 | 1294 | 35 | 14 | 30804502 |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | TARDBP ALYREF SAFB HNRNPUL1 HRNR DDX50 HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 1.05e-11 | 430 | 35 | 10 | 38172120 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | TARDBP ALYREF SAFB HNRNPUL1 DDX50 GAR1 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 1.15e-11 | 807 | 35 | 12 | 22681889 |
| Pubmed | 1.99e-11 | 22 | 35 | 5 | 12456657 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | TARDBP ALYREF NUP214 HNRNPA1L2 HNRNPUL1 KLHDC10 HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 2.12e-11 | 462 | 35 | 10 | 31138677 |
| Pubmed | ALYREF NUP214 SAFB HNRNPUL1 GAR1 TRIP12 HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 2.92e-11 | 660 | 35 | 11 | 32780723 | |
| Pubmed | 5.23e-11 | 65 | 35 | 6 | 32521226 | ||
| Pubmed | TARDBP ALYREF CAAP1 SAFB HNRNPUL1 DDX50 GAR1 HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 6.64e-11 | 713 | 35 | 11 | 29802200 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | TARDBP ALYREF HNRNPA1L2 SAFB HNRNPUL1 DDX50 HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 6.74e-11 | 714 | 35 | 11 | 28302793 |
| Pubmed | 7.34e-11 | 136 | 35 | 7 | 26979993 | ||
| Pubmed | ALYREF SAFB HNRNPUL1 KLHDC10 DDX50 GAR1 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 8.66e-11 | 731 | 35 | 11 | 29298432 | |
| Pubmed | TARDBP SAFB HNRNPUL1 HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 1.05e-10 | 244 | 35 | 8 | 29884807 | |
| Pubmed | DDX3Y HNRNPA1L2 DDX50 TRIP12 HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 1.08e-10 | 245 | 35 | 8 | 21182205 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TARDBP ALYREF SAFB HNRNPUL1 HRNR DDX50 GAR1 TRIP12 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 1.19e-10 | 1257 | 35 | 13 | 36526897 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | TARDBP ALYREF SAFB HNRNPUL1 DDX50 GAR1 TRIP12 HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 1.20e-10 | 989 | 35 | 12 | 36424410 |
| Pubmed | 1.68e-10 | 153 | 35 | 7 | 28225217 | ||
| Pubmed | 1.73e-10 | 260 | 35 | 8 | 36199071 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | TARDBP DDX3Y CAAP1 NUP214 SAFB HNRNPUL1 DDX50 GAR1 TRIP12 HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 2.13e-10 | 1318 | 35 | 13 | 30463901 |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | TARDBP ALYREF SAFB SALL3 ARID3A HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 2.22e-10 | 411 | 35 | 9 | 35182466 |
| Pubmed | TARDBP SAFB HNRNPUL1 HNRNPA1 PCDH7 HNRNPA2B1 HNRNPAB HNRNPA3 | 2.62e-10 | 274 | 35 | 8 | 34244482 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | ALYREF SAFB HRNR DDX50 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 2.93e-10 | 605 | 35 | 10 | 28977666 |
| Pubmed | TARDBP ALYREF SAFB HNRNPUL1 DDX50 GAR1 HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 6.03e-10 | 652 | 35 | 10 | 31180492 | |
| Pubmed | GRIA1 TARDBP HNRNPA1L2 SAFB KRT75 DDX50 GAR1 TRIP12 HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 6.38e-10 | 1442 | 35 | 13 | 35575683 | |
| Pubmed | DDX3Y ALYREF HNRNPA1L2 HNRNPUL1 HRNR KRT75 DDX50 GAR1 HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 6.87e-10 | 1153 | 35 | 12 | 29845934 | |
| Pubmed | Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis. | 9.34e-10 | 3 | 35 | 3 | 23827524 | |
| Pubmed | A widespread sequence-specific mRNA decay pathway mediated by hnRNPs A1 and A2/B1. | 9.34e-10 | 3 | 35 | 3 | 27151978 | |
| Pubmed | AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis. | 1.10e-09 | 200 | 35 | 7 | 35546148 | |
| Pubmed | 1.24e-09 | 109 | 35 | 6 | 29511296 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | DDX3Y ALYREF CAAP1 HNRNPA1L2 SAFB HNRNPUL1 DDX50 HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 1.35e-09 | 949 | 35 | 11 | 36574265 |
| Pubmed | 1.63e-09 | 114 | 35 | 6 | 31553912 | ||
| Pubmed | 1.72e-09 | 115 | 35 | 6 | 17332742 | ||
| Pubmed | 1.92e-09 | 52 | 35 | 5 | 26265008 | ||
| Pubmed | 2.34e-09 | 223 | 35 | 7 | 20020773 | ||
| Pubmed | TARDBP ALYREF SAFB HNRNPUL1 HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 2.88e-09 | 551 | 35 | 9 | 34728620 | |
| Pubmed | FGF11 induced by hypoxia interacts with HIF-1α and enhances its stability. | 3.28e-09 | 128 | 35 | 6 | 28027390 | |
| Pubmed | HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy. | 3.73e-09 | 4 | 35 | 3 | 12945950 | |
| Pubmed | Decrease in hnRNP A/B expression during erythropoiesis mediates a pre-mRNA splicing switch. | 3.73e-09 | 4 | 35 | 3 | 12426391 | |
| Pubmed | 4.01e-09 | 241 | 35 | 7 | 23125841 | ||
| Pubmed | FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3. | 4.89e-09 | 248 | 35 | 7 | 27926873 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 6.42e-09 | 258 | 35 | 7 | 37794589 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TARDBP ALYREF NUP214 SAFB HNRNPUL1 DDX50 GAR1 HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 7.43e-09 | 1425 | 35 | 12 | 30948266 |
| Pubmed | ALYREF SAFB HNRNPUL1 AMOTL2 DDX50 GAR1 HNRNPA1 HNRNPA2B1 HNRNPA3 | 7.47e-09 | 615 | 35 | 9 | 31048545 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 7.86e-09 | 148 | 35 | 6 | 32538781 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | TARDBP SAFB HNRNPUL1 HRNR DDX50 GAR1 HNRNPA1 HNRNPA2B1 HNRNPA3 | 8.71e-09 | 626 | 35 | 9 | 33644029 |
| Pubmed | 9.32e-09 | 5 | 35 | 3 | 38279469 | ||
| Pubmed | 9.32e-09 | 5 | 35 | 3 | 20133837 | ||
| Pubmed | 1.61e-08 | 295 | 35 | 7 | 26209609 | ||
| Pubmed | TERRA transcripts are bound by a complex array of RNA-binding proteins. | 1.73e-08 | 28 | 35 | 4 | 20975687 | |
| Pubmed | 1.74e-08 | 169 | 35 | 6 | 23665500 | ||
| Pubmed | Binding of DAZAP1 and hnRNPA1/A2 to an exonic splicing silencer in a natural BRCA1 exon 18 mutant. | 1.86e-08 | 6 | 35 | 3 | 18391021 | |
| Pubmed | Identifying and quantifying in vivo methylation sites by heavy methyl SILAC. | 2.31e-08 | 30 | 35 | 4 | 15782174 | |
| Pubmed | TARDBP ALYREF NUP214 HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 2.51e-08 | 491 | 35 | 8 | 22623428 | |
| Pubmed | 3.17e-08 | 90 | 35 | 5 | 23151878 | ||
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 3.17e-08 | 90 | 35 | 5 | 35654790 | |
| Pubmed | HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy. | 3.26e-08 | 7 | 35 | 3 | 32086392 | |
| Pubmed | Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3. | 3.62e-08 | 332 | 35 | 7 | 30595499 | |
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 3.70e-08 | 333 | 35 | 7 | 32665550 | |
| Pubmed | 3.70e-08 | 333 | 35 | 7 | 36779763 | ||
| Pubmed | Cdc37 interacts with the glycine-rich loop of Hsp90 client kinases. | 3.90e-08 | 34 | 35 | 4 | 16611982 | |
| Pubmed | ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection. | 3.93e-08 | 336 | 35 | 7 | 31253590 | |
| Pubmed | 4.26e-08 | 340 | 35 | 7 | 24332808 | ||
| Pubmed | Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations. | 4.38e-08 | 96 | 35 | 5 | 25948554 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ALYREF HNRNPUL1 DDX50 GAR1 TRIP12 VIRMA HNRNPA2B1 HNRNPAB HNRNPA3 | 4.55e-08 | 759 | 35 | 9 | 35915203 |
| Pubmed | Proteomic dissection of the von Hippel-Lindau (VHL) interactome. | 4.86e-08 | 98 | 35 | 5 | 21942715 | |
| Pubmed | 4.90e-08 | 347 | 35 | 7 | 16033648 | ||
| Pubmed | hnRNP A1B, a Splice Variant of HNRNPA1, Is Spatially and Temporally Regulated. | 5.21e-08 | 8 | 35 | 3 | 34630013 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TARDBP ALYREF NUP214 SAFB HNRNPUL1 DDX50 TRIP12 HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 5.23e-08 | 1353 | 35 | 11 | 29467282 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 5.38e-08 | 774 | 35 | 9 | 15302935 | |
| Pubmed | ALYREF CAAP1 HNRNPA1L2 SAFB HNRNPUL1 HRNR GAR1 HNRNPA1 HNRNPAB | 6.13e-08 | 786 | 35 | 9 | 29128334 | |
| Pubmed | 7.48e-08 | 216 | 35 | 6 | 37640791 | ||
| Pubmed | PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. | 7.68e-08 | 217 | 35 | 6 | 31685992 | |
| Pubmed | 8.30e-08 | 109 | 35 | 5 | 12226669 | ||
| Pubmed | TARDBP DDX3Y HNRNPA1L2 HNRNPUL1 HRNR HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 1.12e-07 | 844 | 35 | 9 | 25963833 | |
| Pubmed | TARDBP SAFB DDX50 TRIP12 HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 1.16e-07 | 847 | 35 | 9 | 35850772 | |
| Pubmed | DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer. | 1.33e-07 | 238 | 35 | 6 | 35864588 | |
| Pubmed | 1.36e-07 | 239 | 35 | 6 | 26641092 | ||
| Pubmed | 1.82e-07 | 421 | 35 | 7 | 34650049 | ||
| Pubmed | 1.94e-07 | 425 | 35 | 7 | 21081503 | ||
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 2.00e-07 | 130 | 35 | 5 | 35545047 | |
| Pubmed | The biogenesis of the coiled body during early mouse development. | 2.04e-07 | 12 | 35 | 3 | 7768196 | |
| Pubmed | Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer. | 2.25e-07 | 52 | 35 | 4 | 24591637 | |
| Pubmed | TARDBP ALYREF NUP214 HNRNPUL1 DDX50 HNRNPA1 HNRNPA2B1 HNRNPA3 | 2.28e-07 | 655 | 35 | 8 | 35819319 | |
| Pubmed | 2.49e-07 | 441 | 35 | 7 | 31239290 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TARDBP NUP214 SAFB HNRNPUL1 DDX50 LIMD1 HNRNPA1 HNRNPAB DDX42 | 2.64e-07 | 934 | 35 | 9 | 33916271 |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 2.71e-07 | 670 | 35 | 8 | 22990118 | |
| Pubmed | TARDBP DDX3Y ALYREF NUP214 HNRNPUL1 AMOTL2 TRIP12 HNRNPA1 HNRNPA2B1 HNRNPA3 | 2.74e-07 | 1247 | 35 | 10 | 27684187 | |
| Pubmed | Regulation of alternative splicing by SRrp86 and its interacting proteins. | 3.27e-07 | 57 | 35 | 4 | 14559993 | |
| Pubmed | 3.37e-07 | 14 | 35 | 3 | 24553115 | ||
| Pubmed | 3.45e-07 | 463 | 35 | 7 | 34901782 | ||
| Pubmed | IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA. | 3.51e-07 | 58 | 35 | 4 | 21642987 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 3.66e-07 | 283 | 35 | 6 | 30585729 | |
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 3.69e-07 | 147 | 35 | 5 | 28977470 | |
| Pubmed | 3.90e-07 | 286 | 35 | 6 | 32041737 | ||
| Pubmed | 4.21e-07 | 15 | 35 | 3 | 26320552 | ||
| Interaction | SMC5 interactions | TARDBP DDX3Y ALYREF CAAP1 NUP214 HNRNPA1L2 SAFB SALL3 HNRNPUL1 DDX50 GAR1 TRIP12 HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 6.16e-14 | 1000 | 34 | 17 | int:SMC5 |
| Interaction | MECP2 interactions | SP1 TARDBP DDX3Y CAAP1 SAFB GPC2 HNRNPUL1 HRNR DDX50 GAR1 TRIP12 HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 5.14e-11 | 1287 | 34 | 16 | int:MECP2 |
| Interaction | CUL2 interactions | TARDBP ALYREF NUP214 HNRNPUL1 HRNR KRT75 KLHDC10 TRIP12 HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 1.10e-10 | 591 | 34 | 12 | int:CUL2 |
| Interaction | MYCN interactions | SP1 TARDBP ALYREF HNRNPA1L2 SAFB HNRNPUL1 HRNR AMOTL2 KLHDC10 DDX50 GAR1 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 1.35e-10 | 1373 | 34 | 16 | int:MYCN |
| Interaction | MEPCE interactions | DDX3Y ALYREF HNRNPA1L2 HNRNPUL1 HRNR KRT75 DDX50 TRIP12 HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 5.66e-10 | 859 | 34 | 13 | int:MEPCE |
| Interaction | SYNCRIP interactions | GRIA1 TARDBP ALYREF HNRNPUL1 GAR1 VIRMA HNRNPA1 PCDH7 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 1.07e-09 | 721 | 34 | 12 | int:SYNCRIP |
| Interaction | SNRPC interactions | TARDBP ALYREF SAFB HNRNPUL1 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 1.82e-09 | 440 | 34 | 10 | int:SNRPC |
| Interaction | FCMR interactions | 2.21e-09 | 11 | 34 | 4 | int:FCMR | |
| Interaction | PRC1 interactions | TARDBP ALYREF HNRNPA1L2 SAFB HNRNPUL1 HRNR DDX50 GAR1 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 2.58e-09 | 973 | 34 | 13 | int:PRC1 |
| Interaction | CIT interactions | TARDBP DDX3Y ALYREF HNRNPA1L2 SAFB HNRNPUL1 DDX50 GAR1 TRIP12 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 3.35e-09 | 1450 | 34 | 15 | int:CIT |
| Interaction | ANKRD12 interactions | 4.22e-09 | 37 | 34 | 5 | int:ANKRD12 | |
| Interaction | SNRPA interactions | ALYREF CAAP1 SAFB HNRNPUL1 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 4.37e-09 | 482 | 34 | 10 | int:SNRPA |
| Interaction | CUL7 interactions | TARDBP ALYREF NUP214 SAFB HNRNPUL1 DDX50 GAR1 HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 6.39e-09 | 845 | 34 | 12 | int:CUL7 |
| Interaction | NUPR1 interactions | ALYREF NUP214 SAFB HNRNPUL1 GAR1 TRIP12 HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 8.79e-09 | 683 | 34 | 11 | int:NUPR1 |
| Interaction | ZC3H18 interactions | SP1 ALYREF SAFB HNRNPUL1 KLHDC10 DDX50 GAR1 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 9.68e-09 | 877 | 34 | 12 | int:ZC3H18 |
| Interaction | CPSF6 interactions | ALYREF CAAP1 SAFB HNRNPUL1 DDX50 VIRMA HNRNPA1 HNRNPA2B1 DDX42 HNRNPA3 | 1.01e-08 | 526 | 34 | 10 | int:CPSF6 |
| Interaction | EPX interactions | 1.21e-08 | 16 | 34 | 4 | int:EPX | |
| Interaction | OBSL1 interactions | ALYREF NUP214 SAFB HNRNPUL1 DDX50 GAR1 TRIP12 HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 1.32e-08 | 902 | 34 | 12 | int:OBSL1 |
| Interaction | HEXIM1 interactions | DDX3Y ALYREF HNRNPA1L2 HNRNPUL1 HRNR KRT75 DDX50 HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 1.52e-08 | 913 | 34 | 12 | int:HEXIM1 |
| Interaction | CUL4B interactions | ALYREF NUP214 SAFB HNRNPUL1 KRT75 DDX50 GAR1 HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 1.70e-08 | 728 | 34 | 11 | int:CUL4B |
| Interaction | G6PC2 interactions | 1.75e-08 | 4 | 34 | 3 | int:G6PC2 | |
| Interaction | METTL14 interactions | TARDBP DDX3Y ALYREF HNRNPUL1 HRNR VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 1.76e-08 | 558 | 34 | 10 | int:METTL14 |
| Interaction | GATA4 interactions | SP1 TARDBP ALYREF SAFB SALL3 HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 1.87e-08 | 411 | 34 | 9 | int:GATA4 |
| Interaction | SFPQ interactions | SP1 TARDBP ALYREF VIRMA HNRNPA1 PCDH7 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 1.92e-08 | 563 | 34 | 10 | int:SFPQ |
| Interaction | SNRNP70 interactions | TARDBP ALYREF CAAP1 SAFB HNRNPUL1 DDX50 GAR1 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 3.47e-08 | 984 | 34 | 12 | int:SNRNP70 |
| Interaction | OR9Q2 interactions | 4.38e-08 | 5 | 34 | 3 | int:OR9Q2 | |
| Interaction | RBM45 interactions | 4.63e-08 | 207 | 34 | 7 | int:RBM45 | |
| Interaction | GLDC interactions | TARDBP SAFB HNRNPUL1 HNRNPA1 PCDH7 HNRNPA2B1 HNRNPAB HNRNPA3 | 4.81e-08 | 321 | 34 | 8 | int:GLDC |
| Interaction | DOT1L interactions | TARDBP ALYREF SAFB DDX50 TRIP12 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 4.88e-08 | 807 | 34 | 11 | int:DOT1L |
| Interaction | NUMA1 interactions | ALYREF NUP214 HNRNPA1L2 KRT75 TRIP12 VIRMA HNRNPA1 HNRNPA2B1 HNRNPA3 | 5.80e-08 | 469 | 34 | 9 | int:NUMA1 |
| Interaction | KIF23 interactions | TARDBP ALYREF HNRNPA1L2 SAFB HNRNPUL1 HRNR DDX50 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 5.81e-08 | 1031 | 34 | 12 | int:KIF23 |
| Interaction | RBM39 interactions | TARDBP ALYREF CAAP1 HNRNPA1L2 SAFB HNRNPUL1 DDX50 HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 6.52e-08 | 1042 | 34 | 12 | int:RBM39 |
| Interaction | KIF20A interactions | TARDBP ALYREF HNRNPA1L2 SAFB HNRNPUL1 DDX50 GAR1 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 7.24e-08 | 1052 | 34 | 12 | int:KIF20A |
| Interaction | SNRPB interactions | ALYREF CAAP1 SAFB VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 1.33e-07 | 517 | 34 | 9 | int:SNRPB |
| Interaction | LARP7 interactions | DDX3Y ALYREF HNRNPA1L2 HNRNPUL1 HRNR KRT75 DDX50 GAR1 HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 1.34e-07 | 1113 | 34 | 12 | int:LARP7 |
| Interaction | CAND1 interactions | TARDBP ALYREF HNRNPUL1 KRT75 DDX50 GAR1 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 1.38e-07 | 894 | 34 | 11 | int:CAND1 |
| Interaction | IFI16 interactions | SP1 NUP214 HNRNPA1L2 SAFB HNRNPUL1 DDX50 TRIP12 VIRMA HNRNPA1 HNRNPAB | 1.77e-07 | 714 | 34 | 10 | int:IFI16 |
| Interaction | MIR98 interactions | 1.94e-07 | 78 | 34 | 5 | int:MIR98 | |
| Interaction | NR2C2 interactions | TARDBP DDX3Y CAAP1 NUP214 SAFB HNRNPUL1 DDX50 GAR1 TRIP12 HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 1.99e-07 | 1403 | 34 | 13 | int:NR2C2 |
| Interaction | PRMT1 interactions | TARDBP ALYREF SAFB HNRNPUL1 GAR1 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 2.03e-07 | 929 | 34 | 11 | int:PRMT1 |
| Interaction | NAA20 interactions | 2.06e-07 | 31 | 34 | 4 | int:NAA20 | |
| Interaction | ATG16L1 interactions | SP1 TARDBP ALYREF CAAP1 SAFB HNRNPUL1 ARID3A TRIP12 HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 | 2.12e-07 | 1161 | 34 | 12 | int:ATG16L1 |
| Interaction | CHD4 interactions | SAFB SALL3 HRNR DDX50 TRIP12 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 2.24e-07 | 938 | 34 | 11 | int:CHD4 |
| Interaction | HNRNPA1 interactions | TARDBP ALYREF HNRNPA1L2 SAFB HNRNPUL1 HRNR HNRNPA1 PCDH7 HNRNPA2B1 HNRNPAB HNRNPA3 | 2.41e-07 | 945 | 34 | 11 | int:HNRNPA1 |
| Interaction | C2orf78 interactions | 2.44e-07 | 8 | 34 | 3 | int:C2orf78 | |
| Interaction | VHL interactions | SP1 TARDBP DDX3Y LIMD1 TRIP12 HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 2.65e-07 | 561 | 34 | 9 | int:VHL |
| Interaction | RIOK1 interactions | DDX3Y HNRNPUL1 DDX50 GAR1 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 2.69e-07 | 562 | 34 | 9 | int:RIOK1 |
| Interaction | EED interactions | TARDBP ALYREF NUP214 SAFB HNRNPUL1 DDX50 TRIP12 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 2.80e-07 | 1445 | 34 | 13 | int:EED |
| Interaction | DDX5 interactions | SP1 TARDBP ALYREF HNRNPUL1 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 2.94e-07 | 568 | 34 | 9 | int:DDX5 |
| Interaction | TAF15 interactions | TARDBP SAFB HNRNPUL1 HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 3.02e-07 | 408 | 34 | 8 | int:TAF15 |
| Interaction | DNAH2 interactions | 3.02e-07 | 34 | 34 | 4 | int:DNAH2 | |
| Interaction | FUS interactions | TARDBP ALYREF SAFB HNRNPUL1 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 3.05e-07 | 757 | 34 | 10 | int:FUS |
| Interaction | CHD3 interactions | ALYREF SAFB HRNR DDX50 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 3.05e-07 | 757 | 34 | 10 | int:CHD3 |
| Interaction | SF3A2 interactions | 3.05e-07 | 273 | 34 | 7 | int:SF3A2 | |
| Interaction | DCUN1D1 interactions | 3.20e-07 | 275 | 34 | 7 | int:DCUN1D1 | |
| Interaction | FGF11 interactions | 3.65e-07 | 170 | 34 | 6 | int:FGF11 | |
| Interaction | DNAH6 interactions | 3.83e-07 | 36 | 34 | 4 | int:DNAH6 | |
| Interaction | PRPF8 interactions | ALYREF HNRNPUL1 KRT75 KLHDC10 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB SPINK5 HNRNPA3 | 3.83e-07 | 776 | 34 | 10 | int:PRPF8 |
| Interaction | NUDCD2 interactions | 4.04e-07 | 424 | 34 | 8 | int:NUDCD2 | |
| Interaction | CELF1 interactions | 4.37e-07 | 288 | 34 | 7 | int:CELF1 | |
| Interaction | BRCA1 interactions | SP1 TARDBP ALYREF NUP214 HNRNPUL1 GAR1 MYOZ1 HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 4.66e-07 | 1249 | 34 | 12 | int:BRCA1 |
| Interaction | DDRGK1 interactions | TARDBP ALYREF CAAP1 HNRNPUL1 DDX50 GAR1 TRIP12 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 4.66e-07 | 1249 | 34 | 12 | int:DDRGK1 |
| Interaction | STARD9 interactions | 4.78e-07 | 38 | 34 | 4 | int:STARD9 | |
| Interaction | PTBP1 interactions | 5.08e-07 | 437 | 34 | 8 | int:PTBP1 | |
| Interaction | HNRNPF interactions | ALYREF HNRNPA1L2 SAFB HNRNPUL1 KRT75 VIRMA HNRNPA1 HNRNPA2B1 HNRNPA3 | 5.14e-07 | 607 | 34 | 9 | int:HNRNPF |
| Interaction | MIR363 interactions | 5.80e-07 | 97 | 34 | 5 | int:MIR363 | |
| Interaction | AIMP2 interactions | 5.92e-07 | 446 | 34 | 8 | int:AIMP2 | |
| Interaction | HNRNPU interactions | TARDBP ALYREF SAFB HNRNPUL1 DDX50 VIRMA HNRNPA1 PCDH7 HNRNPA2B1 HNRNPAB HNRNPA3 | 5.97e-07 | 1035 | 34 | 11 | int:HNRNPU |
| Interaction | LMNA interactions | ALYREF NUP214 HNRNPA1L2 HNRNPUL1 ARID3A GAR1 VIRMA HNRNPA1 PCDH7 HNRNPA2B1 DDX42 HNRNPA3 | 6.37e-07 | 1286 | 34 | 12 | int:LMNA |
| Interaction | RPA4 interactions | 6.55e-07 | 452 | 34 | 8 | int:RPA4 | |
| Interaction | TNPO1 interactions | 6.58e-07 | 306 | 34 | 7 | int:TNPO1 | |
| Interaction | FUBP1 interactions | 7.02e-07 | 309 | 34 | 7 | int:FUBP1 | |
| Interaction | MIRLET7D interactions | 7.09e-07 | 101 | 34 | 5 | int:MIRLET7D | |
| Interaction | HNRNPC interactions | TARDBP HNRNPA1L2 SAFB DDX50 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 7.40e-07 | 634 | 34 | 9 | int:HNRNPC |
| Interaction | HNRNPH2 interactions | 7.49e-07 | 312 | 34 | 7 | int:HNRNPH2 | |
| Interaction | RBMX interactions | TARDBP HNRNPA1L2 SAFB HNRNPUL1 HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 7.60e-07 | 461 | 34 | 8 | int:RBMX |
| Interaction | WWP2 interactions | ALYREF SAFB HNRNPUL1 AMOTL2 DDX50 GAR1 VIRMA HNRNPA1 HNRNPA2B1 HNRNPA3 | 7.91e-07 | 840 | 34 | 10 | int:WWP2 |
| Interaction | HIPK3 interactions | 8.74e-07 | 44 | 34 | 4 | int:HIPK3 | |
| Interaction | HNRNPK interactions | TARDBP ALYREF SAFB GAR1 VIRMA HNRNPA1 PCDH7 HNRNPA2B1 HNRNPAB HNRNPA3 | 9.10e-07 | 853 | 34 | 10 | int:HNRNPK |
| Interaction | U2AF2 interactions | TARDBP ALYREF SAFB VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 9.22e-07 | 651 | 34 | 9 | int:U2AF2 |
| Interaction | BIRC3 interactions | TARDBP ALYREF NUP214 SAFB HNRNPUL1 DDX50 GAR1 HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 9.42e-07 | 1334 | 34 | 12 | int:BIRC3 |
| Interaction | MATR3 interactions | TARDBP ALYREF HNRNPA1L2 SAFB HNRNPUL1 VIRMA HNRNPA1 HNRNPA2B1 HNRNPA3 | 9.70e-07 | 655 | 34 | 9 | int:MATR3 |
| Interaction | DDX23 interactions | 1.03e-06 | 480 | 34 | 8 | int:DDX23 | |
| Interaction | DHX9 interactions | TARDBP ALYREF HNRNPUL1 VIRMA HNRNPA1 PCDH7 HNRNPA2B1 HNRNPAB HNRNPA3 | 1.06e-06 | 662 | 34 | 9 | int:DHX9 |
| Interaction | CYLD interactions | GRIA1 TARDBP ALYREF NUP214 HNRNPUL1 HRNR KLHDC10 VIRMA HNRNPA1 HNRNPAB | 1.07e-06 | 868 | 34 | 10 | int:CYLD |
| Interaction | COPS5 interactions | ALYREF HNRNPUL1 HRNR KRT75 MYOZ1 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 1.11e-06 | 1102 | 34 | 11 | int:COPS5 |
| Interaction | PPIA interactions | TARDBP DDX3Y ALYREF SAFB SALL3 LIMD1 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB | 1.31e-06 | 888 | 34 | 10 | int:PPIA |
| Interaction | CDK9 interactions | TARDBP ALYREF NUP214 SAFB TRIP12 HNRNPA1 HNRNPA2B1 DDX42 HNRNPA3 | 1.41e-06 | 685 | 34 | 9 | int:CDK9 |
| Interaction | H3C1 interactions | HNRNPA1L2 ARID3A GAR1 TRIP12 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 1.49e-06 | 901 | 34 | 10 | int:H3C1 |
| Interaction | H2AC4 interactions | 1.53e-06 | 506 | 34 | 8 | int:H2AC4 | |
| Interaction | RNF113A interactions | TARDBP ALYREF NUP214 HNRNPUL1 DDX50 HNRNPA1 PCDH7 HNRNPA2B1 HNRNPA3 | 1.53e-06 | 692 | 34 | 9 | int:RNF113A |
| Interaction | SCARNA22 interactions | 1.54e-06 | 118 | 34 | 5 | int:SCARNA22 | |
| Interaction | EWSR1 interactions | TARDBP ALYREF SAFB HNRNPUL1 HRNR VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 1.57e-06 | 906 | 34 | 10 | int:EWSR1 |
| Interaction | HNRNPA0 interactions | 1.58e-06 | 349 | 34 | 7 | int:HNRNPA0 | |
| Interaction | TOP1 interactions | TARDBP ALYREF SAFB VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB DDX42 HNRNPA3 | 1.60e-06 | 696 | 34 | 9 | int:TOP1 |
| Interaction | GRSF1 interactions | TARDBP ALYREF HNRNPUL1 DDX50 HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 1.74e-06 | 515 | 34 | 8 | int:GRSF1 |
| Interaction | ERG interactions | 1.78e-06 | 223 | 34 | 6 | int:ERG | |
| Interaction | TARDBP interactions | TARDBP HNRNPUL1 DDX50 VIRMA HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 1.87e-06 | 520 | 34 | 8 | int:TARDBP |
| Interaction | MTF1 interactions | 1.88e-06 | 123 | 34 | 5 | int:MTF1 | |
| Interaction | DDX21 interactions | TARDBP ALYREF SAFB DDX50 HNRNPA1 PCDH7 HNRNPA2B1 HNRNPAB HNRNPA3 | 2.07e-06 | 718 | 34 | 9 | int:DDX21 |
| Cytoband | 12q13.1 | 3.71e-05 | 12 | 35 | 2 | 12q13.1 | |
| Cytoband | 10q22.1 | 5.72e-04 | 46 | 35 | 2 | 10q22.1 | |
| GeneFamily | RNA binding motif containing | TARDBP ALYREF HNRNPA1L2 SAFB HNRNPA1 HNRNPA2B1 HNRNPAB HNRNPA3 | 4.24e-10 | 213 | 26 | 8 | 725 |
| GeneFamily | DEAD-box helicases | 2.92e-05 | 42 | 26 | 3 | 499 | |
| Coexpression | FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL | 1.02e-05 | 380 | 35 | 6 | M41703 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | SP1 TARDBP HNRNPA1L2 HNRNPUL1 KLHDC10 TRIP12 HNRNPA1 HNRNPA2B1 HNRNPAB | 1.55e-05 | 1158 | 35 | 9 | MM1338 |
| Coexpression | MISSIAGLIA_REGULATED_BY_METHYLATION_DN | 2.09e-05 | 122 | 35 | 4 | M6866 | |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN | 2.47e-05 | 669 | 35 | 7 | M18635 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | SP1 TARDBP HNRNPUL1 KLHDC10 TRIP12 HNRNPA1 HNRNPA2B1 HNRNPAB | 9.63e-05 | 1129 | 35 | 8 | M42508 |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_UP | 1.35e-04 | 197 | 35 | 4 | M5150 | |
| Coexpression | GSE14308_TH1_VS_INDUCED_TREG_DN | 1.43e-04 | 200 | 35 | 4 | M3379 | |
| Coexpression | GSE43955_1H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN | 1.43e-04 | 200 | 35 | 4 | M9685 | |
| Coexpression | HALLMARK_MYC_TARGETS_V1 | 1.43e-04 | 200 | 35 | 4 | M5926 | |
| Coexpression | CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB | 1.56e-04 | 14 | 35 | 2 | M1659 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_EARLY_SUPRABASAL_CELLS | 1.61e-04 | 79 | 35 | 3 | M40003 | |
| Coexpression | PAL_PRMT5_TARGETS_UP | 1.73e-04 | 210 | 35 | 4 | MM1172 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_EARLY_FIBROBLAST | 1.73e-04 | 81 | 35 | 3 | M45667 | |
| Coexpression | CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB | 2.05e-04 | 16 | 35 | 2 | MM699 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.54e-07 | 188 | 35 | 5 | 8bd6f2cd1aadbd6f9ed31b160f59c1eff144e1dc | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-4|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 8.56e-06 | 166 | 35 | 4 | 52293b8a74d46e6161fb6a2e7e86e51fd9e89a5b | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.18e-05 | 180 | 35 | 4 | 44988c34861df359a68376500c42a64fbcc4b431 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.23e-05 | 182 | 35 | 4 | f549b986caebc5eb1b2d12f34fe33087e8324a31 | |
| ToppCell | 3'|World / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-05 | 186 | 35 | 4 | e265aac37f33947ff6c83f23f8a2c63bbccd60af | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-stalk_early|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.46e-05 | 190 | 35 | 4 | 9f5f65869dad9a43ac94f81f9a19c72ffe5adc3c | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Early_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.75e-05 | 199 | 35 | 4 | d67f5ae05daf942fb79f5b962021f37f4e275f4d | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4-POLYDENDROCYTE_(Neurogenesis.Sox4.Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.25e-04 | 124 | 35 | 3 | 1483be8700eca7e2c288784a290d945d4022b17f | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-4|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.41e-04 | 129 | 35 | 3 | 003a3202053986c2eb10d5e84b90ab33b7ee37e3 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.65e-04 | 136 | 35 | 3 | 3e13dc0634f3b05e9f9e6c3193f843f62e603b78 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.65e-04 | 136 | 35 | 3 | 0185486c39700dd2f72d79be6d283494dd8379c9 | |
| ToppCell | PBMC-Mild-cDC_3|Mild / Compartment, Disease Groups and Clusters | 2.56e-04 | 158 | 35 | 3 | 5fefab4831687cd8dd45f5cc84f681398069c3be | |
| ToppCell | Basal_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.86e-04 | 164 | 35 | 3 | 85487a303194f5244956ec1ca2d1758d38117f41 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.51e-04 | 176 | 35 | 3 | ce85a13e10cf37f5cf38ca8b0bac6701b6d00ffd | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.57e-04 | 177 | 35 | 3 | cbad1a23851151dbef01ea2af960e6f0944f838b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.57e-04 | 177 | 35 | 3 | ce86dfaeb74d995a19aea62f0fb15c4c0bb854b0 | |
| ToppCell | LPS-antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.63e-04 | 178 | 35 | 3 | 289d1425c4e57fabcca994b27f9af1c0ce5d5bec | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.06e-04 | 185 | 35 | 3 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.06e-04 | 185 | 35 | 3 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-04 | 186 | 35 | 3 | 9a7932d0a208f3997216bd21a72913cc82b59fc9 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-04 | 187 | 35 | 3 | 4d12c70c8ed922fbc8f7b139145611203735cab4 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-04 | 187 | 35 | 3 | e851ee46a6b4068a7bd7602ee183c0ace50ee4dd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-04 | 187 | 35 | 3 | e46b49b4053d2d0f3e1d2bcdc380f7f8733cbe07 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.33e-04 | 189 | 35 | 3 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | facs-Skin-Anagen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-04 | 189 | 35 | 3 | adbfc723130079b4caf551f66d2aee86fab1903c | |
| ToppCell | facs-Skin-Anagen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-04 | 190 | 35 | 3 | 3466cebab16964e94da130d0673fa32e7d90b5ed | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-04 | 190 | 35 | 3 | 888ded899f0513d41bf655896d59ae8ef74e0978 | |
| ToppCell | Control-Epithelial-Basal/Club|Control / Disease group,lineage and cell class (2021.01.30) | 4.39e-04 | 190 | 35 | 3 | 799b0b1c4bdbe04ee0fc34d0be9e02b5992774a0 | |
| ToppCell | E15.5-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.46e-04 | 191 | 35 | 3 | 6f5d91a9583bbb30dfaa30dd9c7772995a9196be | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 4.53e-04 | 192 | 35 | 3 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | E15.5-Epithelial-epithelial_progenitor_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.53e-04 | 192 | 35 | 3 | cb6f42dcffe650f7958543531d8f5412b2f2eb12 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.67e-04 | 194 | 35 | 3 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | E12.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.67e-04 | 194 | 35 | 3 | 4b335e4da58de1cd94194dc4208ce83854e5e50a | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.67e-04 | 194 | 35 | 3 | f64da5f62e29253d60b9546edf734ba5c17daae1 | |
| ToppCell | droplet-Marrow-BM-1m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-04 | 195 | 35 | 3 | 637b06ef3967b03f7165d102d316e8b7161a817d | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.81e-04 | 196 | 35 | 3 | 6ba02b806d440eed45bad7616bf3b8be57034427 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 4.88e-04 | 197 | 35 | 3 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.88e-04 | 197 | 35 | 3 | 19cf283537c853fa902852e7b8ac1139729a931a | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.88e-04 | 197 | 35 | 3 | 31dfd9842410b5c629f39b5130233995dceb0aef | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.88e-04 | 197 | 35 | 3 | 7290f05d0b8465637420119941bcbf2fae44a7e4 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.88e-04 | 197 | 35 | 3 | 78122e1fb80e0ac3084dd4f7c551996330a701df | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.88e-04 | 197 | 35 | 3 | 106b0f9a0425facc634feb7498c9ba2c55edfbf8 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.88e-04 | 197 | 35 | 3 | e14a0e8a893c72356afc5508e3531ae0b23bfe16 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Early_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.95e-04 | 198 | 35 | 3 | ecf0a8f2e07f336e23b6f32a2c48d3c7eb66572b | |
| ToppCell | myeloid-CD34+_Monoblast|myeloid / Lineage and Cell class | 4.95e-04 | 198 | 35 | 3 | e26b98a8380e693110a97d8e5a353998f8d67c6d | |
| ToppCell | 5'-Adult-Distal_Rectal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.95e-04 | 198 | 35 | 3 | db26c20321f9ab102d6484f22ddb2bde684067b1 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.95e-04 | 198 | 35 | 3 | 9c0535099750698daac5d6b4d39fb19fecf4ffde | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.95e-04 | 198 | 35 | 3 | a1c8e5c332336823c47c04e56b6d7bc8f057c9da | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 4.95e-04 | 198 | 35 | 3 | 6d12ecaa9532c134d9c4562534dcb59a6420b4d3 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like-IPs_and_early_cortical_neurons|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 4.95e-04 | 198 | 35 | 3 | 7943e4f67c3d6efb5c8b00aa0ff3cfe7be10c48d | |
| ToppCell | Bronchial_Biopsy|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.95e-04 | 198 | 35 | 3 | f5b7013045b61fc56894f80092f799770dde1c8f | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.03e-04 | 199 | 35 | 3 | ea75804c34989c99aab542e6d72617ed144819b6 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.03e-04 | 199 | 35 | 3 | 8e7f9312dec1e3a92b6a0ccc7baa2d46e89c11f3 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.03e-04 | 199 | 35 | 3 | fe3b7d540a644dfc6beea171c809b4d1ba4e188f | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Basophilic_Erythroblast|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 5.03e-04 | 199 | 35 | 3 | 6f159c1215439ec22374903124085746fa8da333 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 5.03e-04 | 199 | 35 | 3 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.03e-04 | 199 | 35 | 3 | 59915b6db86fd0cc83a0bf9a3a1dda08522ec8d3 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.03e-04 | 199 | 35 | 3 | 713dfd8552635645db5e0b5721c64e5c9b4aa06c | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.03e-04 | 199 | 35 | 3 | 8daf945fc93169b0a4fa3ef9f4a87eedd52e314a | |
| ToppCell | HSPCs|World / Lineage and Cell class | 5.03e-04 | 199 | 35 | 3 | df1ffc416c6946f1ba182f242a50ee41a571d565 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.03e-04 | 199 | 35 | 3 | cdee798e3586e4e7a15de598239090a85752ea1e | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.03e-04 | 199 | 35 | 3 | be425e9cb90a73289026b1b7cb581e1c02a8985e | |
| ToppCell | lymphoid-T_cell-CD8+_Naive_T_cell|T_cell / Lineage, cell class and subclass | 5.03e-04 | 199 | 35 | 3 | 9ee40563e840a7fe97e7592539d42e19db438c64 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.03e-04 | 199 | 35 | 3 | dadee9fc6ce4f4bdb19d29326889316443dda0cb | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 5.10e-04 | 200 | 35 | 3 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | critical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.10e-04 | 200 | 35 | 3 | f39db4250ce220a3eb58edee3f7fc3671701d46f | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.10e-04 | 200 | 35 | 3 | 4234bdc70a9941d4bf77148d75bd271e0c114b88 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-OPC_related-Oligodendrocyte/OPC|2m / Sample Type, Dataset, Time_group, and Cell type. | 5.10e-04 | 200 | 35 | 3 | 3c9a2f02294a9fb892b89e856291bd6423ffa0a9 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Mesoderm|5w / Sample Type, Dataset, Time_group, and Cell type. | 5.10e-04 | 200 | 35 | 3 | 0927061536a664b4f7feb9e5b0a8c11ca0d5955c | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.10e-04 | 200 | 35 | 3 | 364f09eb9ae4913f5c80a29e943e1c0b2ffd5f93 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.10e-04 | 200 | 35 | 3 | 19a4213f180ac2d29625d140b602a93a74ab3fdd | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Neuron|3m / Sample Type, Dataset, Time_group, and Cell type. | 5.10e-04 | 200 | 35 | 3 | 3d134ae3c48ff4d1849db4fbe44ff73fb6c8c779 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.10e-04 | 200 | 35 | 3 | 0fd9a8730b7dc461ddf4586899d363541e72d8ba | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-OPC_related|2m / Sample Type, Dataset, Time_group, and Cell type. | 5.10e-04 | 200 | 35 | 3 | 8e49e7e9b02d8411e4ffae1f5113a2c18f5bf179 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.10e-04 | 200 | 35 | 3 | c28d4ca51d2e2a3a22784ee251975f16a55b0297 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.10e-04 | 200 | 35 | 3 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.10e-04 | 200 | 35 | 3 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.10e-04 | 200 | 35 | 3 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| Computational | Neighborhood of FBL | 9.72e-06 | 140 | 23 | 5 | MORF_FBL | |
| Computational | Neighborhood of XRCC5 | 1.17e-04 | 235 | 23 | 5 | MORF_XRCC5 | |
| Computational | Neighborhood of UBE2I | 1.24e-04 | 238 | 23 | 5 | MORF_UBE2I | |
| Computational | Neighborhood of PPP2CA | 1.47e-04 | 129 | 23 | 4 | MORF_PPP2CA | |
| Computational | Neighborhood of DENR | 1.67e-04 | 51 | 23 | 3 | GNF2_DENR | |
| Computational | Neighborhood of DEK | 2.01e-04 | 264 | 23 | 5 | MORF_DEK | |
| Computational | Neighborhood of FBL | 2.37e-04 | 146 | 23 | 4 | GNF2_FBL | |
| Computational | Neighborhood of BUB3 | 2.52e-04 | 277 | 23 | 5 | MORF_BUB3 | |
| Computational | Neighborhood of ESPL1 | 2.84e-04 | 61 | 23 | 3 | MORF_ESPL1 | |
| Computational | Neighborhood of SMC1L1 | 2.98e-04 | 62 | 23 | 3 | MORF_SMC1L1 | |
| Computational | RNA splicing. | 3.43e-04 | 65 | 23 | 3 | MODULE_183 | |
| Computational | Neighborhood of GNB1 | 3.93e-04 | 305 | 23 | 5 | MORF_GNB1 | |
| Computational | Neighborhood of RBBP6 | 4.27e-04 | 70 | 23 | 3 | GNF2_RBBP6 | |
| Computational | Neighborhood of CUL1 | 4.64e-04 | 72 | 23 | 3 | MORF_CUL1 | |
| Computational | Neighborhood of NPM1 | 4.64e-04 | 72 | 23 | 3 | GNF2_NPM1 | |
| Computational | Neighborhood of RAD23A | 7.19e-04 | 348 | 23 | 5 | MORF_RAD23A | |
| Computational | Neighborhood of ANP32B | 7.51e-04 | 198 | 23 | 4 | MORF_ANP32B | |
| Computational | Neighborhood of APEX1 | 9.49e-04 | 92 | 23 | 3 | GNF2_APEX1 | |
| Computational | Neighborhood of ACP1 | 9.53e-04 | 211 | 23 | 4 | MORF_ACP1 | |
| Computational | Neighborhood of RAD54L | 1.39e-03 | 105 | 23 | 3 | MORF_RAD54L | |
| Computational | Genes in the cancer module 32. | 1.56e-03 | 241 | 23 | 4 | MODULE_32 | |
| Computational | Neighborhood of HDAC1 | 1.89e-03 | 254 | 23 | 4 | MORF_HDAC1 | |
| Computational | Neighborhood of DNMT1 | 1.95e-03 | 118 | 23 | 3 | MORF_DNMT1 | |
| Computational | Neighborhood of DAP3 | 1.99e-03 | 119 | 23 | 3 | GNF2_DAP3 | |
| Computational | Neighborhood of RAN | 2.30e-03 | 268 | 23 | 4 | MORF_RAN | |
| Computational | Neighborhood of TDG | 2.50e-03 | 35 | 23 | 2 | GNF2_TDG | |
| Computational | Neighborhood of AP3D1 | 2.56e-03 | 130 | 23 | 3 | MORF_AP3D1 | |
| Computational | Neighborhood of HDAC2 | 2.70e-03 | 280 | 23 | 4 | MORF_HDAC2 | |
| Computational | Neighborhood of ANP32B | 2.79e-03 | 37 | 23 | 2 | GNF2_ANP32B | |
| Computational | Neighborhood of CSNK2B | 2.95e-03 | 287 | 23 | 4 | MORF_CSNK2B | |
| Computational | Neighborhood of RFC4 | 3.92e-03 | 151 | 23 | 3 | MORF_RFC4 | |
| Computational | Neighborhood of CTBP1 | 5.28e-03 | 168 | 23 | 3 | MORF_CTBP1 | |
| Computational | Neighborhood of G22P1 | 5.63e-03 | 172 | 23 | 3 | MORF_G22P1 | |
| Computational | Neighborhood of HAT1 | 5.91e-03 | 175 | 23 | 3 | MORF_HAT1 | |
| Computational | Neighborhood of FEN1 | 6.29e-03 | 56 | 23 | 2 | GNF2_FEN1 | |
| Computational | Neighborhood of DEK | 6.73e-03 | 58 | 23 | 2 | GNF2_DEK | |
| Computational | Neighborhood of RPA1 | 7.42e-03 | 61 | 23 | 2 | MORF_RPA1 | |
| Computational | Neighborhood of MSH2 | 7.42e-03 | 61 | 23 | 2 | MORF_MSH2 | |
| Computational | Neighborhood of PRKDC | 7.53e-03 | 191 | 23 | 3 | MORF_PRKDC | |
| Computational | Neighborhood of SNRP70 | 7.66e-03 | 62 | 23 | 2 | MORF_SNRP70 | |
| Computational | Neighborhood of SART1 | 7.90e-03 | 63 | 23 | 2 | MORF_SART1 | |
| Computational | Neighborhood of DAP3 | 7.97e-03 | 195 | 23 | 3 | MORF_DAP3 | |
| Computational | Neighborhood of ST13 | 8.15e-03 | 64 | 23 | 2 | GNF2_ST13 | |
| Computational | Neighborhood of DDX5 | 8.39e-03 | 65 | 23 | 2 | GCM_DDX5 | |
| Computational | Neighborhood of FEN1 | 8.39e-03 | 65 | 23 | 2 | MORF_FEN1 | |
| Computational | Neighborhood of TERF1 | 8.90e-03 | 67 | 23 | 2 | MORF_TERF1 | |
| Computational | Neighborhood of AATF | 9.63e-03 | 209 | 23 | 3 | MORF_AATF | |
| Computational | Neighborhood of CDK2 | 1.02e-02 | 72 | 23 | 2 | MORF_CDK2 | |
| Computational | Neighborhood of XRCC5 | 1.11e-02 | 75 | 23 | 2 | GNF2_XRCC5 | |
| Computational | Neighborhood of CDC16 | 1.11e-02 | 75 | 23 | 2 | MORF_CDC16 | |
| Computational | Neighborhood of UNG | 1.13e-02 | 76 | 23 | 2 | MORF_UNG | |
| Drug | AC1NRA5C | 2.06e-07 | 174 | 34 | 6 | CID005287709 | |
| Drug | NSC53670 | 5.39e-07 | 44 | 34 | 4 | CID000243583 | |
| Drug | SK&F 83959 | 3.05e-06 | 153 | 34 | 5 | ctd:C080703 | |
| Drug | AC1L1AUZ | 3.46e-06 | 157 | 34 | 5 | CID000001160 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 3.58e-10 | 145 | 35 | 7 | DOID:1289 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 2.88e-09 | 48 | 35 | 5 | DOID:423 (implicated_via_orthology) | |
| Disease | autosomal dominant limb-girdle muscular dystrophy type 3 (implicated_via_orthology) | 3.05e-08 | 6 | 35 | 3 | DOID:0110306 (implicated_via_orthology) | |
| Disease | Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | 4.10e-06 | 3 | 35 | 2 | cv:C1833662 | |
| Disease | INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA | 4.10e-06 | 3 | 35 | 2 | C1833662 | |
| Disease | Amyotrophic Lateral Sclerosis | 4.51e-05 | 58 | 35 | 3 | C0002736 | |
| Disease | uterine prolapse | 1.62e-04 | 16 | 35 | 2 | EFO_1001864 | |
| Disease | Alzheimer's disease (is_marker_for) | 3.48e-03 | 257 | 35 | 3 | DOID:10652 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QQALRGGAGTGGTGS | 36 | Q9Y2J4 | |
| GNANFSGSVTGGGSG | 56 | Q9H8G2 | |
| SSQRGRRGSGNFGGG | 191 | Q32P51 | |
| GGNDNFGRGGNFSGR | 211 | Q32P51 | |
| SSQRGRSGSGNFGGG | 146 | A0A2R8Y4L2 | |
| GGNDNFGRGGNFSGR | 166 | A0A2R8Y4L2 | |
| EGSLGGQNSGIGGRS | 241 | Q9UGP4 | |
| GGSARYNQGRSRSGG | 541 | Q8N158 | |
| DQRNAAGHGSSGGGG | 686 | Q9NQ38 | |
| RAGTGGSSQGRHTGG | 1056 | Q5JUK3 | |
| ASGNNSREGTGGSNG | 791 | Q86XP3 | |
| SGGSGGRGTGQLNRF | 31 | Q6PID8 | |
| GNGASGGGSGGSKRR | 211 | O60245 | |
| QSSGYGRQGSGSGQS | 1111 | Q86YZ3 | |
| SRQSSGHGRQGSGSG | 1226 | Q86YZ3 | |
| QSSGYGRQGSGSGQS | 1581 | Q86YZ3 | |
| SRQSSGHGRQGSGSG | 1696 | Q86YZ3 | |
| QSSGYGRQGSGSGQS | 2051 | Q86YZ3 | |
| SRQSSGHGRQGSGSG | 2166 | Q86YZ3 | |
| QSSGYGRQGSGSGQS | 2521 | Q86YZ3 | |
| SRQSSGHGRQGSGSG | 2636 | Q86YZ3 | |
| SGNTGRGGGFFSGLG | 1876 | P35658 | |
| GRSGGRSGGRSGRQS | 691 | Q9BQ39 | |
| FGASRGSSSRSGGGG | 611 | O15523 | |
| GSSSRSGGGGYGNSR | 616 | O15523 | |
| RNSGAGASSGGSGEN | 861 | P42261 | |
| RAARGGAGGGAQSQG | 61 | Q7Z3Z3 | |
| FSQGARAAGGSGAGG | 181 | Q9BXA9 | |
| RGGFNRSGGGGYSQN | 656 | Q9BUJ2 | |
| GGGGFNRGGSSNHFR | 16 | Q9NY12 | |
| GSGGRGNRNRGNRGS | 241 | Q99729 | |
| GSASNAGSGSGFNGG | 386 | Q13148 | |
| ERSSVGSGNTAGGGG | 1361 | Q6ZNJ1 | |
| GTRTAQGSGGGAGRG | 326 | Q7Z4P5 | |
| GGNGNGGGAFSQARS | 26 | P08047 | |
| GGMQGGFGGQSRGSR | 891 | Q15424 | |
| GSSSNAGGRGGNTGT | 556 | Q99856 | |
| AGGRGGNTGTSGGQA | 561 | Q99856 | |
| VQSSRSGRGGNFGFG | 196 | P22626 | |
| SRNSGSGVAGGGSGG | 231 | Q5TF21 | |
| GSQRGRGGGSGNFMG | 211 | P51991 | |
| RGGGSGNFMGRGGNF | 216 | P51991 | |
| SSQRGRSGSGNFGGG | 191 | P09651 | |
| GGNDNFGRGGNFSGR | 211 | P09651 | |
| SGNGTGGSFSLNRGS | 1241 | Q14669 | |
| NSGSGGSRGKFVSGG | 1786 | Q69YN4 | |
| RAGSQGGRGGGAQAA | 31 | Q86V81 | |
| LGGSGFSATSNRGLG | 516 | O95678 | |
| NGRGGSQAGGSGSAG | 111 | Q9NP98 |